The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 181, 73 -80
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, P.
Right arrow Articles by Zaghouani, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, P.
Right arrow Articles by Zaghouani, H.

Fetal Exposure to High-Avidity TCR Ligand Enhances Expansion of Peripheral T Regulatory Cells1

Ping Yu2,*, Cara L. Haymaker*, Rohit D. Divekar*, Jason S. Ellis*, John Hardaway*, Renu Jain*, Danielle M. Tartar*, Christine M. Hoeman*, Jason A. Cascio*, Austin Ostermeier* and Habib Zaghouani3,*,{dagger}

* Department of Molecular Microbiology and Immunology and {dagger} Department of Child Health, University of Missouri School of Medicine, Columbia, MO 65212

Lately, it has become clear that regulatory T cells (Tregs) play a major role in the maintenance of peripheral tolerance and control of autoimmunity. Despite these critical functions, the process underlying the development of Tregs remains largely undefined. Herein, altered peptide ligand (APL) variants derived from the proteolipid protein-1 (PLP1) epitope were expressed on immunoglobulins (Igs) and the resulting Ig-APLs were used to deliver the APLs from mother to fetus through the maternal placenta to influence thymic T cell selection. This delivery system was then adapted to the SJL/J mouse, a strain that expresses only the DM20 form of PLP, which lacks the dominant PLP1 epitope in the thymus during fetal and neonatal development. This model, which restores thymic T cell selection for PLP1, was then used to determine whether affinity plays a role in the development of Tregs. The findings show that fetal exposure to low-affinity peptide ligand was unable to drive development of Tregs while variants with higher affinity to the TCR resulted in significant seeding of the periphery with mature, naive Tregs. Thus, contrary to pathogenic T cells, Tregs require avid TCR-ligand interaction to undergo thymic development and maturation.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Grants 2RO1 NS37406, RO1 NS057194, and RO1 AI48541 (to H.Z.) from the National Institutes of Health. J.S.E. and C.M.H. were supported by the predoctoral training grant (T32 GM08396) from National Institute of General Medical Sciences. D.M.T., J.A.C., and J.C.H. were supported by a life science fellowship from the University of Missouri.

2 Current address: National Cancer Institute, Metabolism Branch, Bethesda, MD 20892.

3 Address correspondence and reprint requests to Dr. Habib Zaghouani, Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, M616 Medical Sciences Building, Columbia, MO 65212. E-mail address: zaghouanih{at}health.missouri.edu

4 Abbreviations used in this paper: agg, aggregated; APL, altered peptide ligand; EAE, experimental allergic encephalomyelitis; PLP, proteolipid protein; Treg, regulatory T cell; Tg, transgenic.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Shen, M. Zhu, J. Lau, M. Chuck, and W. Zhang
The Essential Role of LAT in Thymocyte Development during Transition from the Double-Positive to Single-Positive Stage
J. Immunol., May 1, 2009; 182(9): 5596 - 5604.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.